Shares of GenVec Inc scaled the charts Friday, which was a day after the Biopharmaceutical Company declared its fourth-quarter loss narrowed as revenue grew slightly and research expenses fell. GenVec Inc trades on the “NASDAQ” under the stock symbol “GNVC”. For the Latest information regarding “GNVC”, make sure to visit the Most Exclusive and In Depth newsletter website at: http://www.wallstreetgrand.com/.
Join today and be part of the best free investment newsletter on the web where we focus on market moving news.
Shares of GenVec Inc. (NASDAQ:GNVC) scaled the charts Friday, which was a day after the Biopharmaceutical Company declared its fourth-quarter loss narrowed as revenue grew slightly and research expenses fell.
The Gaithersburg, Md., company said it lost $4.3 million, or 4 cents per share, compared with a loss of $6.4 million, or 7 cents per share, in the final quarter of 2008. Revenue rose to $3.4 million from $3.3 million.
The drug and vaccine developer said research and development expenses fell 33 percent in the quarter to $5.5 million, due mostly to reduced manufacturing and clinical trial costs for its cancer treatment candidate TNFerade.
The drug is being studied for possible use in treating advanced pancreatic cancer and several other cancers. GenVec said the
You can contact us during market hours at 1-888-9-ClubGrand (1888-925-8247) or via email at staff@wallstreetgrand.com .Gerard@WallStreetGrand.com
Safe Harbor
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") including 2009 growth, revenue for the second quarter and year of 2009 and gross margin for the second quarter and year of 2009. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the impact of intense competition, the continuation or worsening of current economic conditions and the condition of the domestic and global credit and capital markets.
Disclaimer:
Wall Street Grand LLC has not been compensated by the company for this press release and does not expect to be compensated in the future for any type of awareness. To read our full disclaimer clicks the link http://www.wallstreetgrand.com/disclosure.html.
